Precision radiotherapy in neuro-oncology: A PRISMA-based systematic review on targeted nanoparticles as radiosensitizers and theranostic agents in CNS tumors

Puntos clave

• Targeted nanoparticles enhance the efficacy of precision radiotherapy in CNS tumors by acting as radiosensitizers.
• The review evaluates multiple studies on nanoparticles, reporting significant improvements in radiotherapy outcomes in 25% of the cases.
• Systematic review methodology based on PRISMA guidelines ensures comprehensive analysis of available literature on the topic.
• The findings support the potential for nanoparticles in improving treatment options, but further clinical trials are needed.